Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00327236 · ClinicalTrials.gov registry record
The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 109
- Enrollment target
NCT00327236 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 109 participants.
The verdict
NCT00327236 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The investigators believe that T cells, cells that are a part of the immune system, are what are causing the neurological problems while also attacking tumor cells. This protocol studies the clinical status of patients with paraneoplastic neurological disorder (PND) as well as their blood to understand the relationship between their neurological disease, their cancer, and their immune system.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 1995-01 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00327236
The ClinicalTrials.gov registry entry for NCT00327236 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00327236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00327236 about?
NCT00327236 is a clinical study titled "The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes". The investigators believe that T cells, cells that are a part of the immune system, are what are causing the neurological problems while also attacking tumor cells. This protocol studies the clinical status of patients with paraneoplastic neurological disorder (PND) as well as their blood to underst...
What is the current status of trial NCT00327236?
This trial is currently completed. The enrollment target is 109 participants. The study started on 1995-01. Estimated completion is 2018-02.
Who is sponsoring clinical trial NCT00327236?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.